This site has been developed for healthcare professionals who treat people with phenylketonuria (PKU). The site is meant to educate and heighten awareness of the PKU burden of illness, the impact of elevated phenylalanine (Phe), as well as the continued unmet need.1,2
Phenylketonuria (PKU) is an autosomal recessive inborn error of phenylalanine (Phe) metabolism, which can have significant neurodevelopment sequelae.1-3
67% of adults with PKU are above guideline Phe target ranges, increasing the severity of neuropsychological symptoms and negatively impacting life trajectory.4
The effects of high Phe are felt throughout a patient’s life and lead to many typical PKU symptoms.
Register below to connect with a BioMarin representative, learn about upcoming PKU events and news, or request a peer-to-peer discussion.
* Required fields